Richard C. Miner - Concepedia

Author

Richard C. Miner

Also Known As

R C Miner, R Miner, R. C. Miner, R. Miner, R.C Miner, R.C. Miner, RICHARD C. MINER, Richard C. Miner, Richard Miner, Richard C. Miner

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco University of California San Francisco Medical Center Oregon Health & Science University Portland VA Medical Center National Institutes of Health

About

Richard C. Miner is an author at University of California, San Francisco specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.2K
2	Health Sciences	2	2	210
3	Natural Sciences	2	2	251
4	Engineering	1	1	68
5	Allergy	1	1	12

Richard C. Miner

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection William Drew, Richard C. Miner, David F. Busch, The Journal of Infectious Diseases	1991	371
Frequency of UL97 Phosphotransferase Mutations Related to Ganciclovir Resistance in Clinical Cytomegalovirus Isolates S. Chou, Susan Guentzel, K. R. Michels, The Journal of Infectious Diseases	1995	220
Viral DNA Polymerase Mutations Associated with Drug Resistance in Human Cytomegalovirus Sunwen Chou, Nell S. Lurain, Kim D. Thompson, The Journal of Infectious Diseases Viral ReplicationMedicineNatural SciencesImmunologyMolecular Biology	2003	196
Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to Ganciclovir Sunwen Chou, Rachel H. Waldemer, Anne E. Senters, The Journal of Infectious Diseases Molecular VirologyGcv SusceptibilityPathogenesisViral PathogenesisImmunology	2002	191
Evolution of Mutations Conferring Multidrug Resistance during Prophylaxis and Therapy for Cytomegalovirus Disease Sunwen Chou, Gail I. Marousek, Susan Guentzel, The Journal of Infectious Diseases Cmv Pol GeneCytomegalovirus DiseaseImmunologyPathologyAntiviral Drug	1997	177
Multiple Infections by Cytomegalovirus in Patients with Acquired Immunodeficiency Syndrome: Documentation by Southern Blot Hybridization W. Lawrence Drew, Eugenia S. Sweet, Richard C. Miner, The Journal of Infectious Diseases Primary ImmunodeficiencyInfectious Disease EpidemiologyViral PersistenceClinical Infectious DiseaseAcquired Immunodeficiency Syndrome	1984	164
Phase I Dose Escalation Trial Evaluating the Pharmacokinetics, Anti-Human Cytomegalovirus (HCMV) Activity, and Safety of 1263W94 in Human Immunodeficiency Virus-Infected Men with Asymptomatic HCMV Shedding Jacob Lalezari, Judith A. Aberg, Laurene H. Wang, Antimicrobial Agents and Chemotherapy	2002	148
A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates Marie L. Landry, Sylvia C. Stanat, Karen K. Biron, Antimicrobial Agents and Chemotherapy	2000	148
Evaluation of the Virus Permeability of a New Condom for Women W. Lawrence Drew, MARGARET BLAIR, Richard C. Miner, Sexually Transmitted Diseases	1990	117
Cytomegalovirus gB Genotype Distribution Differs in Human Immunodeficiency Virus--Infected Patients and Immunocompromised Allograft Recipients Lucy Rasmussen, Christina Hong, Donato Zipeto, The Journal of Infectious Diseases	1997	88

Page 1